This article summarized the latest R&D progress of teprotumumab-trbw, the Mechanism of Action for teprotumumab-trbw, and the drug target R&D trends for teprotumumab-trbw.
This article summarized the latest R&D progress of thioridazine hydrochloride, the Mechanism of Action for thioridazine hydrochloride, and the drug target R&D trends for thioridazine hydrochloride.
This article summarized the latest R&D progress of tolfenamic acid, the Mechanism of Action for tolfenamic acid, and the drug target R&D trends for tolfenamic acid.
This article summarized the latest R&D progress of taurolidine, the Mechanism of Action for taurolidine, and the drug target R&D trends for taurolidine.
This article summarized the latest R&D progress of tamibarotene, the Mechanism of Action for tamibarotene, and the drug target R&D trends for tamibarotene.
This article summarized the latest R&D progress of sunvozertinib, the Mechanism of Action for sunvozertinib, and the drug target R&D trends for sunvozertinib.
This article summarized the latest R&D progress of sulfadiazine/trimethoprim, the Mechanism of Action for sulfadiazine/trimethoprim, and the drug target R&D trends for sulfadiazine/trimethoprim.
This article summarized the latest R&D progress of rituximab-pvvr, the Mechanism of Action for rituximab-pvvr, and the drug target R&D trends for rituximab-pvvr.
This article summarized the latest R&D progress of ruxolitinib phosphate, the Mechanism of Action for ruxolitinib phosphate, and the drug target R&D trends for ruxolitinib phosphate.
This article summarized the latest R&D progress of salmeterol xinafoate, the Mechanism of Action for salmeterol xinafoate, and the drug target R&D trends for salmeterol xinafoate.
This article summarized the latest R&D progress of serplulimab, the Mechanism of Action for serplulimab, and the drug target R&D trends for serplulimab.
This article summarized the latest R&D progress of strontium ranelate, the Mechanism of Action for strontium ranelate, and the drug target R&D trends for strontium ranelate.